Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Blood|June 10, 2022
Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trialAlexander Röth, Sigbjørn Berentsen, Wilma Barcellini, et al.
Eclinicalmedicine|August 2, 2024
Long-term efficacy and safety of continued complement C1s inhibition with sutimlimab in cold agglutinin disease: CADENZA study Part BAlexander Röth, Sigbjørn Berentsen, Wilma Barcellini, et al.
The New England Journal of Medicine|February 14, 2014
Genetic variants in C5 and poor response to eculizumabJun-ichi Nishimura, Masaki Yamamoto, Shin Hayashi, et al.
American Journal of Hematology|June 17, 2024
Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibitionAlexander Röth, Guangsheng He, Hongyan Tong, et al.
Clinical Pharmacology and Therapeutics|January 20, 2023
Mitigating Drug-Target-Drug Complexes in Patients With Paroxysmal Nocturnal Hemoglobinuria Who Switch C5 InhibitorsJun-Ichi Nishimura, Antoine Soubret, Noriko Arase, et al.
Blood|January 25, 2020
The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuriaAlexander Röth, Jun-Ichi Nishimura, Zsolt Nagy, et al.
Pageof 8